K-numberK243655
Device nameTurbAlign
ApplicantSpirair, Inc.
Product codeLYA
Device classClass I
Decision dateJul 11, 2025
DecisionSubstantially Equivalent
Regulation874.4780
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

TurbAlign is a bioabsorbable polydioxanone implant designed to hold the middle turbinate away from the lateral nasal wall during the healing phase following sinus surgery (such as endoscopic sinus surgery). The device provides short-term fixation of the middle turbinate to the nasal septum to minimize the risk of adhesion to the lateral wall, and it fully resorbs over 180 days.

Technological characteristics

TurbAlign uses an attached surgical needle for threading through tissue structures, whereas the predicate device uses a hook and barb design. TurbAlign has variable length adjustable to anatomical need, compared to the predicate's fixed length. Both devices use absorbable synthetic polymer (polydioxanone), are single-use, sterile, and made of biocompatible materials with similar intended function.

Test standards cited

ISO 10993-1 (Biological Evaluation of Medical Devices – Part 1: Evaluation and testing within a risk management process, 2018); FDA Guidance on Use of International Standard ISO 10993-1 (September 8, 2023). Tests performed included cytotoxicity, sensitization, irritation, implantation, and chemical characterization.

Substantial equivalence argument

Both devices share the same primary technological principle—separating the middle turbinate from the lateral nasal wall using an absorbable synthetic polymer during post-surgical healing. The design differences (attached needle vs. hook-and-barb, variable vs. fixed length) do not raise different safety or effectiveness questions because performance testing—including mechanical integrity, comparative anchoring feature testing, and cadaver usability studies—demonstrated the subject device performs equivalently to the predicate in medializing tissue. Biocompatibility testing confirmed material safety. Therefore, the subject device is substantially equivalent despite these design variations.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →